Jump Financial’s Day One Biopharmaceuticals DAWN Stock Holding History

Jump Financial’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.7M	Sell	497,365 -169,755	-25%	-$2.39M	0.14%	161
2025 Q4	$6.22M	Buy	667,120 +394,573	+145%	+$3.3M	0.08%	314
2025 Q3	$1.92M	Buy	+272,547	New	+$1.88M	0.02%	750
2024 Q4	–	Sell	-38,010	Closed	-$529K	–	1727
2024 Q3	$529K	Buy	+38,010	New	+$542K	0.01%	1080
2024 Q2	–	Sell	-32,142	Closed	-$531K	–	1892
2024 Q1	$531K	Buy	+32,142	New	+$481K	0.01%	1150
2023 Q3	–	Sell	-70,031	Closed	-$836K	–	1926
2023 Q2	$836K	Sell	70,031 -30,357	-30%	-$396K	0.03%	777
2023 Q1	$1.34M	Buy	100,388 +84,024	+513%	+$1.64M	0.05%	489
2022 Q4	$352K	Buy	+16,364	New	+$336K	0.02%	951

Other funds holding DAWN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Jump Financial's DAWN Position: Q1 2026 in Review

Jump Financial reduced its Day One Biopharmaceuticals (DAWN) stake by 25% in Q1 2026, selling an estimated $2.39M and leaving 497,365 shares worth $10.7M. The position accounts for 0.14% of the portfolio, ranked #161.

Jump Financial first reported a position in DAWN in Q4 2022 and has held it in 8 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

Jump Financial held 497,365 shares of Day One Biopharmaceuticals worth $10.7M as of Q1 2026.
Jump Financial sold 169,755 Day One Biopharmaceuticals shares in Q1 2026, an estimated $2.39M.
Day One Biopharmaceuticals made up 0.14% of Jump Financial's portfolio in Q1 2026, its #161 holding.
Jump Financial first reported a position in Day One Biopharmaceuticals in Q4 2022 and has held it in 8 quarters since.
206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.